To investigate the effect of the opioid blocker naltrexone in the inflammatory response in acute pancreatitis (AP). METHODS: Acute pancreatitis was induced in anesthetized male Wistar rats by retrograde injection of 2.5% sodium taurocholate diluted in 0.5ml saline into the main pancreatic duct. Animals were randomized to the following experimental groups: Control Group (n=9): animals received an intraperitoneal injection of saline solution (0.5ml), 15 minutes before the induction of AP. Naltrexone Group (n=9): animals received an intraperitoneal injection of naltrexone 0.5ml (15 mg/kg), 15 minutes before induction of AP. Peritoneal levels of TNF-α and serum levels of IL-6 and amylase were determined The volume of the ascitic fluid was also evaluated. Myeloperoxidase (MPO) activities were analyzed in homogenates of pulmonary tissue. RESULTS: There were no significant differences in the ascitic fluid volume, nor in TNF-a and IL-6 levels in the naltrexone group compared to controls. Treatment with naltrexone did not affect the lung MPO activity compared to control group. CONCLUSIONS: The opioid receptors don't play an important role in the pathogenesis of the inflammatory response in acute pancreatitis. If opioids affect leukocytes inflammatory signaling, there are no major implications in the pathogenesis of acute pancreatitis. Key words: Pancreatitis. Physiopathology. Receptors, Opioid. Naltrexone. Rats.
Introduction
The opioid receptor family consists of the µ(MOR), δ(DOR) and κ (KOR) receptors, belonging to the family of seven transmembrane G-nucleotide binding protein-coupled receptors.
They are found in the central nervous system and in peripheral neurons.
Immune cells also express opioid binding sites and modulation of immune functions (chemotaxis, cytokine production, degranulation, etc) by opioids have been reported 1 .
Studies have also shown that immune cells play a role in the control of inflammatory pain, by the production of endogenous opioid peptides that accumulate in the inflamed tissue. Many substances (corticotrophin releasing factor, cytokines, catecholamines), as well as environmental factors (psychological stress, for example)
can liberate these substances. These effects can be aborted by opioid receptor antagonists.
Endogenous opioids derived from immune cells, as α-and β-endorphin, dynorphin A and B, α-and β-neoendorphin and enkephalins produce potent analgesia. These molecules are the natural ligands for MOR, DOR and KOR. In the early phase of inflammation, most endogenous opioids are produced by granulocytes. Later, monocytes become the main source 2 .
Exogenous opioids, however, are largely used in medicine to treat pain, in diseases such as acute pancreatitis. Naltrexone hydrochloride, which is a drug used to treat alcoholism, has been studied among the several drugs that theoretically could reduce the inflammatory process in AP. It is an opioid receptor antagonist, a synthetic congener of oxymorphone, differing in its molecular structure, because the methyl group on the nitrogen atom is replaced by the cyclopropylmethyl group. Its beneficial effect on the inflammatory process and on the expression of proinflammatory cytokines has been already described 7, 8 .
Previous studies have shown a beneficial effect of naloxone, an analogue of naltrexone, in experimental AP,
suggesting that endogenous opioid peptides may play an important role in the pathogenesis of AP 9, 10 . In fact, Shen et al. 10 showed that these drugs may limit the progression of the disease, especially from the edematous to the hemorrhagic form, suggesting that endogenous opioid peptides may be linked to the pathophysiology of AP. These authors, however, did not evaluate the effects of these substances on the systemic inflammatory process.
We hypothesized that opioid receptors could play a role in the pathogenesis of the inflammatory response in acute pancreatitis.
This current study aims to determine the effects of the opioid blocker naltrexone on the inflammatory mediators in an experimental model of AP.
Methods
The experimental protocol was approved by the Ethics 
Induction of acute pancreatitis
Surgical anesthesia was induced with ketamine chloride 50 mg/ml (0.2ml/100g body weight) (Ketalar; Parke-Davis, Sao
Paulo, Brazil). AP was induced in anesthetized rats by retrograde intraductal injection of 0.5 ml of 2.5% (w/v) sodium taurocholate in 0.9% (w/v) NaCl into the main pancreatic duct for 1 minute at a constant rate using an infusion pump (KD Scientific, Holliston, MA). The proximal part of the hepatic duct was clamped during the injection 11 .
.
Experimental groups
Animals were randomized into the following experimental groups: Results were expressed as optical density (OD) at 460 nm 12 .
Statistical analysis
The groups were compared using Student's t test and results are presented as mean values ± SEM. The level of p<0.05
was considered statistically significant. The data were analyzed using Graphpad Prism ® 4.0 software (San Diego, CA, USA).
Results
The elevated serum amylase levels found in the control group were not affected by naltrexone treatment (p=0.140) ( Figure   1 ). Although opioid receptors alone do not cause inflammation, there is no doubt that they can stimulate lymphocytes and macrophages as well as cytokines production. Indeed, opioid receptors blockade actually reduces inflammation in chemically induced colitis 13 . In fact, naltrexone, an opioid antagonist, is able to block acute endotoxic shock by inhibiting TNFα production 14 .
Deep comprehension of the mechanisms that link opioid receptors and immunity are still lacking, but evidence suggests Neuroendocrine Axis or by the peripheral nerve play an important role 15 .
As already mentioned, Shen et al. 10 
Conclusion
Opioid receptors don't play an important role in the pathogenesis of the systemic inflammatory response in acute pancreatitis.
